by Jacques Lemoisson | Dec 31, 2020
As mentioned in previous posts and in my Outlook, mistrust due to logistic issues is one of the key components favoring the dichotomy of temporality between what markets priced and the timing of the real economy recovery. in addition, side-effects seem to be worse at...
by Jacques Lemoisson | Dec 29, 2020
As usual, the goal of this document is to propose answers to the main questions over 2021. Global economic growth: Rapid catch up (effective vaccines?) or “Groundhog Day” infection? Biden: Post-Trump Era complete shift or simple transition? The USA is back in the...
by Jacques Lemoisson | Dec 26, 2020
Officials in the Chinese capital have warned the public to be on high alert for Covid-19 flare-ups as several districts report new infections, including one of an employee at a U.S. tech giant. The warning comes as several districts in Beijing, including Shunyi and...
by Jacques Lemoisson | Dec 23, 2020
After many articles about vaccines mistrust from healthcare workers, now the same from China. Sinovac might release its phase 3 human trial data on Wednesday but little else is known publicly about the vaccine candidates. We are in the same position in Occident...
by Jacques Lemoisson | Dec 22, 2020
In my previous posts, I addressed the low rate of vaccine adoption. Mistrust is spreading mainly among healthcare workers. The leading U.S. Covid-19 vaccine makers sank on Tuesday as Moderna slumped 11% and BioNTech fell almost 10%. And now the mistrust is bitting the...
by Jacques Lemoisson | Dec 22, 2020
Like in other countries, between 40% to 50% in the USA is not comfortable with Moderna/Pfizer vaccines. Politicians need to demonstrate their confidence in these vaccines by publically trying first! In the end, the biggest “nursing homes” in all countries...